Evidence map›Paper›PMID 18205702›Full record

ReviewJournal of cellular and molecular medicine

T regulatory cells: aid or hindrance in the clearance of disease?

Clint A Coleman, Michaela C Muller-Trutwin, Cristian Apetrei, Ivona Pandrea

Abstract readReview
In one paragraph

Review in Journal of cellular and molecular medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Genetic, Immunologic, and Environmental Basis of Sarcoidosis.Annals of the American Thoracic Society · 2017
    Review
  7. Article
  8. Review
  9. Association of two clones allows for optimal detection of human FOXP3.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2010
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Clint A ColemanDepartment of Microbiology and Immunology, Tulane University Health Sciences Center, New Orleans, LA, USA.
Michaela C Muller-Trutwin
Cristian Apetrei
Ivona Pandrea

Funding

Pathogenesis of SIV in African green monkeysR01AI064066 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VASILE PANDREA, IVONA · 2005 to 2010
$2.8M
Pathogenesis of New SIVsm Lineages in Rhesus MacaquesR01AI065325 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI APETREI, CRISTIAN · 2006 to 2009
$2.6M
T regulatory cells in Rhesus Macaques and African green monkeysR21AI069935 · NIAID · TULANE UNIVERSITY OF LOUISIANA · PI PANDREA, IVONA · 2006 to 2007
$445k
NIAID NIH HHS R01 AI064066NIAID NIH HHS R01 AI065325NIAID NIH HHS R21 AI069935NIAID NIH HHS R21AI069935
6 · The paper itself

Abstract

CD4+ CD25+ T regulatory cells (Tregs) are classified as a subset of T cells whose role is the suppression and regulation of immune responses to self and non-self. Since their discovery in the early 1970s, the role of CD4+ CD25+ Tregs in both autoimmune and infectious disease has continued to expand. This review examines the recent advances on the role CD4+ CD25+ Tregs may be playing in various diseases regarding progression or protection. In addition, advances made in the purification and manipulation of CD4+ CD25+ Tregs using new cell markers, techniques and antibodies are discussed. Ultimately, an overall understanding of the exact mechanism which CD4+ CD25+ Tregs implement during disease progression will enhance our ability to manipulate CD4+ CD25+ Tregs in a clinically beneficial manner.

Indexed as

DiseaseAmino Acid SequenceAnimalsCD4 AntigensForkhead Transcription FactorsHumansInterleukin-2 Receptor alpha SubunitLymphocyte DepletionMolecular Sequence DataT-Lymphocytes, RegulatoryCD4 AntigensForkhead Transcription FactorsInterleukin-2 Receptor alpha Subunit

Identifiers

PMID18205702
PMCPMC4401294

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.